Therapeutic targeting of EPH receptors and their ligands

AW Boyd, PF Bartlett, M Lackmann - Nature reviews Drug discovery, 2014 - nature.com
Critical roles for EPH receptor (EPH)–ephrin signalling in a range of chronic and
regenerative diseases are increasingly being recognized. In particular, the complex roles of …

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

J Wykosky, W Debinski - Molecular Cancer Research, 2008 - AACR
The Eph receptor tyrosine kinases and ephrin ligands have been studied extensively for
their roles in developmental processes. In recent years, Eph receptors and ephrins have …

The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathway

NK Noren, G Foos, CA Hauser, EB Pasquale - Nature cell biology, 2006 - nature.com
Recent evidence supports a role for EphB receptor tyrosine kinases as tumour suppressors
in colorectal and prostate cancer. However, it is unclear how these receptors inhibit cancer …

Eph receptors and ephrins as targets for cancer therapy

HQ Xi, XS Wu, B Wei, L Chen - Journal of cellular and …, 2012 - Wiley Online Library
Eph receptor tyrosine kinases and their ephrin ligands are involved in various signalling
pathways and mediate critical steps of a wide variety of physiological and pathological …

Ephrins and Eph receptors in stem cells and cancer

M Genander, J Frisén - Current opinion in cell biology, 2010 - Elsevier
Eph tyrosine kinase receptors and their ephrin ligands are expressed in most adult stem cell
niches and in many types of tumors. They maintain tissue homeostasis by controlling the …

Eph receptors in cancer

S Arora, AM Scott, PW Janes - Biomedicines, 2023 - mdpi.com
Eph receptor tyrosine kinases play critical functions during development, in the formation of
tissue and organ borders, and the vascular and neural systems. Uniquely among tyrosine …

Receptor tyrosine kinase EphB4 is a survival factor in breast cancer

SR Kumar, J Singh, G Xia, V Krasnoperov… - The American journal of …, 2006 - Elsevier
EphB4, a member of the largest family of receptor tyrosine kinases, is normally expressed on
endothelial and neuronal cells. Although aberrant expression of EphB4 has been reported …

Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome

DM Brantley-Sieders, A Jiang, K Sarma… - PloS one, 2011 - journals.plos.org
Pre-clinical studies provide compelling evidence that Eph family receptor tyrosine kinases
(RTKs) and ligands promote cancer growth, neovascularization, invasion, and metastasis …

The clinical impact of the eph/ephrin system in cancer: Unwinding the thread

A Pergaris, E Danas, D Goutas, AG Sykaras… - International Journal of …, 2021 - mdpi.com
Erythropoietin-producing human hepatocellular receptors (EPHs) compose the largest
known subfamily of receptor tyrosine kinases (RTKs). They bind and interact with the EPH …

Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor

J Wykosky, E Palma, DM Gibo, S Ringler, CP Turner… - Oncogene, 2008 - nature.com
The ephrinA1 ligand exerts antioncogenic effects in tumor cells through activation and
downregulation of the EphA2 receptor and has been described as a membrane-anchored …